Topic: United States
(Reuters) - U.S. regulators on Monday revised the label for Sanofi SA's heart drug Multaq to reflect a doubling of health risks, including death, for some patients with irregular heart rhythms.In the updated label, the Food and Drug Administration said Multaq, known ...
CHICAGO (Reuters) - U.S. health regulators said they are still investigating a rare but serious problem with Boston Scientific Corp's new heart stents and required the company to caution doctors about it when the device was approved last month.The Food and Drug ...
ADELPHI, Maryland (Reuters) - U.S. drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch be simplified to better explain the risk of blood clots.In a 20 to 3 vote with one abstention, advisers to the Food ...
ADELPHI, Maryland (Reuters) - U.S. health advisers recommended a revision of labels for the widely used new generation of birth control pills, based on data showing they may put women at a higher risk of dangerous blood clots.Although all common birth control ...
ADELPHI, Maryland (Reuters) - U.S. health advisers recommended a revision of labels for the widely used new generation of birth control pills, based on data showing they may put women at a higher risk of dangerous blood clots.Although all common birth control ...
Pakistan's embattled President Asif Ali Zardari will remain in hospital in Dubai until further notice after suffering a minor heart attack and undergoing an operation, officials said on Wednesday.The unpopular 56-year-old head of state flew to the United Arab Emirates on Tuesday ...
WASHINGTON (Reuters) - U.S. health regulators on Monday said a CardioMEMs implant for treating heart failure met its main safety and effectiveness targets but warned of potential bias in the company's research.A Food and Drug Administration staff review of the CardioMEMS Champion ...
NEW YORK (Reuters Health) - In a new study from a single California community, women who had been pregnant at least four times were less likely to die from cardiovascular disease than those who'd never been expecting.Researchers said that could be due ...
NEW YORK (Reuters Health) - A quick transfer from one hospital to another with more sophisticated facilities can be a lifesaver for heart attack patients -- but quick transfers are a rarity in the U.S., researchers said Monday.In a nationwide study published ...
NEW YORK (Reuters Health) - One out of every 10 people who get a stent inserted to open up blocked arteries ends up back in the hospital within 30 days, suggests a new study that also found the readmitted patients are more ...